Covered recipient · General Payments record
LISA STEHLI KELLY
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$1,096.11
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.71 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $123.43 | 5 |
| PFIZER INC. | $106.40 | 5 |
| Verrica Pharmaceuticals Inc. | $37.78 | 2 |
| Phadia US Inc. | $17.46 | 1 |
| Vertical Pharmaceuticals, LLC | $16.73 | 1 |
| Cranial Technologies, Inc | $16.62 | 1 |
| Kaleo, Inc. | $16.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Cranial Technologies, Inc | $16.62 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082232412 | CMS |
| kaleo, Inc. | $16.29 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126627397 | CMS |
| Merck Sharp & Dohme LLC | $21.03 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141982353 | CMS |
| Merck Sharp & Dohme LLC | $26.01 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141971689 | CMS |
| Merck Sharp & Dohme LLC | $25.29 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141651131 | CMS |
| Merck Sharp & Dohme LLC | $23.22 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141853135 | CMS |
| Merck Sharp & Dohme LLC | $27.88 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141651129 | CMS |
| PFIZER INC. | $25.54 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131249405 | CMS |
| PFIZER INC. | $21.92 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131410978 | CMS |
| PFIZER INC. | $24.66 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131570697 | CMS |
| PFIZER INC. | $17.75 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131769734 | CMS |
| PFIZER INC. | $16.53 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132109179 | CMS |
| Phadia US Inc. | $17.46 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067582402 | CMS |
| Verrica Pharmaceuticals Inc. | $16.90 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118382568 | CMS |
| Verrica Pharmaceuticals Inc. | $20.88 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118382570 | CMS |
| Vertical Pharmaceuticals, LLC | $16.73 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126993544 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.